Segall Bryant & Hamill LLC Makes New Investment in Chemed Co. (NYSE:CHE)

Segall Bryant & Hamill LLC bought a new position in shares of Chemed Co. (NYSE:CHE) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 24,311 shares of the company’s stock, valued at approximately $12,880,000. Segall Bryant & Hamill LLC owned 0.16% of Chemed as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in CHE. State Street Corp boosted its position in shares of Chemed by 0.8% during the third quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after purchasing an additional 3,564 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Chemed by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after buying an additional 15,791 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in shares of Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after buying an additional 22,105 shares in the last quarter. FMR LLC grew its position in shares of Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after buying an additional 45,917 shares during the period. Finally, Copeland Capital Management LLC increased its stake in shares of Chemed by 16.8% in the 4th quarter. Copeland Capital Management LLC now owns 151,623 shares of the company’s stock worth $80,330,000 after acquiring an additional 21,834 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Brian C. Judkins purchased 145 shares of the firm’s stock in a transaction dated Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares of the company’s stock, valued at approximately $871,721. The trade was a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada boosted their price target on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.

Chemed Price Performance

Shares of NYSE:CHE opened at $608.54 on Wednesday. The business has a fifty day moving average price of $570.74 and a 200-day moving average price of $565.85. The company has a market capitalization of $8.91 billion, a PE ratio of 30.75, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $646.71.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. Chemed’s dividend payout ratio is currently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.